Geode Capital Management, LLC Mannkind Corp Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 6,338,928 shares of MNKD stock, worth $37.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,338,928

Previous 6,314,897 0.38%

Holding current value

$37.7 Million

Previous $33 Million 20.77%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.01 - $6.7 $120,395 - $161,007	24,031 Added 0.38%	6,338,928 $39.8 Million
Q2 2024 Aug 09, 2024	BUY	$4.05 - $5.43 $1.17 Million - $1.56 Million	288,082 Added 4.78%	6,314,897 $33 Million
Q1 2024 May 13, 2024	BUY	$3.25 - $5.27 $598,130 - $969,890	184,040 Added 3.15%	6,026,815 $27.3 Million
Q4 2023 Feb 13, 2024	BUY	$3.34 - $4.29 $1.09 Million - $1.41 Million	327,795 Added 5.94%	5,842,775 $21.3 Million
Q3 2023 Nov 13, 2023	BUY	$3.91 - $5.45 $705,524 - $983,403	180,441 Added 3.38%	5,514,980 $22.8 Million
Q2 2023 Aug 11, 2023	BUY	$3.72 - $4.79 $660,125 - $849,999	177,453 Added 3.44%	5,334,539 $21.7 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $952,226 - $1.36 Million	241,070 Added 4.9%	5,157,086 $21.1 Million
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $752,230 - $1.34 Million	249,083 Added 5.34%	4,916,016 $25.9 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $346,113 - $503,542	115,757 Added 2.54%	4,666,933 $14.4 Million
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $44,511 - $79,520	16,671 Added 0.37%	4,551,176 $17.3 Million
Q1 2022 May 13, 2022	BUY	$2.62 - $4.45 $690,231 - $1.17 Million	263,447 Added 6.17%	4,534,505 $16.7 Million
Q4 2021 Feb 11, 2022	BUY	$4.05 - $5.37 $53,200 - $70,540	13,136 Added 0.31%	4,271,058 $18.7 Million
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $117,898 - $166,087	30,308 Added 0.72%	4,257,922 $18.5 Million
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.45 $1.41 Million - $2.13 Million	391,598 Added 10.21%	4,227,614 $23 Million
Q1 2021 May 12, 2021	BUY	$3.14 - $6.14 $1.72 Million - $3.37 Million	548,627 Added 16.69%	3,836,016 $15 Million
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $422,747 - $954,134	236,172 Added 7.74%	3,287,389 $10.3 Million
Q3 2020 Nov 13, 2020	BUY	$1.56 - $2.08 $138,668 - $184,891	88,890 Added 3.0%	3,051,217 $5.74 Million
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $259,481 - $610,057	276,044 Added 10.28%	2,962,327 $5.18 Million
Q1 2020 May 14, 2020	BUY	$0.84 - $1.76 $127,764 - $267,697	152,101 Added 6.0%	2,686,283 $2.77 Million
Q4 2019 Feb 13, 2020	BUY	$1.14 - $1.49 $108,534 - $141,856	95,206 Added 3.9%	2,534,182 $3.27 Million
Q3 2019 Nov 12, 2019	BUY	$1.04 - $1.44 $42,556 - $58,924	40,920 Added 1.71%	2,438,976 $3.05 Million
Q2 2019 Aug 14, 2019	BUY	$1.09 - $1.88 $268,179 - $462,547	246,036 Added 11.43%	2,398,056 $2.76 Million
Q1 2019 May 14, 2019	BUY	$1.14 - $2.25 $553,944 - $1.09 Million	485,916 Added 29.16%	2,152,020 $4.24 Million
Q4 2018 Feb 13, 2019	BUY	$1.02 - $2.05 $206,922 - $415,873	202,865 Added 13.86%	1,666,104 $1.77 Million
Q3 2018 Nov 13, 2018	BUY	$1.01 - $2.19 $277,620 - $601,969	274,872 Added 23.13%	1,463,239 $2.68 Million
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $928,561 - $1.39 Million	584,001 Added 96.63%	1,188,367 $2.26 Million
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $120,379 - $200,632	52,798 Added 9.57%	604,366 $1.38 Million
Q4 2017 Feb 13, 2018	BUY	$2.28 - $6.71 $160,835 - $473,336	70,542 Added 14.66%	551,568 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $121,847 - $242,634	105,954 Added 28.25%	481,026 $1.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	375,072	375,072 $528,000

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.53B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Mannkind Corp Transaction History